CLINICAL_TRIALS
trial_result
· 2016-03-15
Clinical Trial Update: A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy [Phase 1]
Summary
Pfizer conducted a Phase 1 monotherapy trial in Japanese subjects with Type 2 Diabetes Mellitus; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-03-15